{
  "created_at": "Mon May 10 10:51:50 +0000 2021",
  "id_str": "1391686980820520962",
  "full_text": "Pfizer partner BioNTech plans to start making Covid-19 vaccines in 2023 at a new Asia headquarters in Singapore https://t.co/bO9AhjmJpV",
  "display_text_range": [
    0,
    135
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/bO9AhjmJpV",
        "expanded_url": "https://on.wsj.com/3hkEANz",
        "display_url": "on.wsj.com/3hkEANz",
        "indices": [
          112,
          135
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 30,
  "favorite_count": 98,
  "possibly_sensitive": false,
  "original_created_at": "Mon May 10 09:30:07 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "Pfizer社のパートナーであるBioNTech社は、2023年にシンガポールの新しいアジア本部でCovid-19ワクチンの製造を開始する予定です https://t.co/bO9AhjmJpV"
    },
    {
      "locale": "zh",
      "full_text": "辉瑞公司的合作伙伴BioNTech计划于2023年在新加坡的新亚洲总部开始生产Covid-19疫苗https://t.co/bO9AhjmJpV。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "輝瑞公司的合作伙伴BioNTech計劃於2023年在新加坡的新亞洲總部開始生產Covid-19疫苗https://t.co/bO9AhjmJpV。"
    }
  ]
}